Skip to main content
FinSpry Logo
FinSpry
URGN logo
URGN
(NASDAQ)
UroGen Pharma Ltd.
$45.00-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

UroGen Pharma (URGN) Stock Price & Financial Analysis

UroGen Pharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$43.77 - $47.06
52-Week High$50.81
52-Week Low$15.86
Open$43.82
Volume1.02M
Average Volume (3M)878.20K
Market Cap2.26B
Shares Outstanding50.18M
Price to Sales (P/S)16.07
Price to Book (P/B)-18.17
EV/EBITDA-20.25
Revenue (TTM)140.49M
Net Income (TTM)-133.22M
Free Cash Flow (TTM)-166.03M
EPS (TTM)$-2.73
Profit Margin-94.83%
Operating Margin-77.02%
50-Day MA$43.01
200-Day MA$28.47
52-Week Change117.50%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About UroGen Pharma

What is the current stock price for URGN?

As of the latest trading session, URGN stock trades at $45.00. The 52-week range is $15.86–$50.81, with a day range of $43.77–$47.06.

What is the P/E ratio for URGN?

The P/E ratio (Price-to-Earnings) for URGN is shown in the Key Statistics section. This valuation metric helps compare UroGen Pharma Ltd. to industry peers.

Does URGN pay dividends?

UroGen Pharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for URGN?

Based on 2 analysts, the consensus for URGN is Buy.

What is the market cap of URGN?

UroGen Pharma's market capitalization is $2.26B, classifying it as a mid-cap company. UroGen Pharma operates in the Healthcare sector within the Biotechnology industry.